Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899140-25-000405
Filing Date
2025-03-06
Accepted
2025-03-06 21:30:18
Documents
1
Period of Report
2025-03-04

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 10017
  Complete submission text file 0000899140-25-000405.txt   12318
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Issuer) CIK: 0001080014 (see all company filings)

EIN.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SARISSA CAPITAL MANAGEMENT LP 660 STEAMBOAT ROAD, 3RD FLOOR GREENWICH CT 06830
Business Address
DENNER ALEXANDER J (Reporting) CIK: 0001361754 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30319 | Film No.: 25717369

Mailing Address 660 STEAMBOAT ROAD GREENWICH CT 06830
Business Address 660 STEAMBOAT ROAD GREENWICH CT 06830 203-302-2330
Sarissa Capital Management LP (Reporting) CIK: 0001577524 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-30319 | Film No.: 25717368